Skip to content
UPST$21.23-0.10(-0.47%)Upstart Q3 net income up on record contribution profit7:27:18 AM ETXMTR$101.22+6.16(+6.48%)Manufacturing marketplace Xometry beats Q3 estimates; raises FY revenue outlook7:26:58 AM ETPFE$30.83+0.13(+0.42%)UPDATE 2-Pfizer raises 2026 forecasts as Eliquis, cancer drugs drive Q3 beat7:26:25 AM ETSHOP$132.57-23.63(-15.13%)UPDATE 1-Shopify Q3 revenue rises 32%, GMV hits $119 bln7:24:54 AM ETAAPL$324.64-13.95(-4.12%)Apple Has Gotten ‘Zero Out of AI.' Bulls Say It Doesn't Matter Yet.7:20:31 AM ETORCL$117.01-2.11(-1.77%)5 Days After Promising to Limit Fundraising, Oracle Hit the Limit7:19:03 AM ETNVDA$205.55+3.35(+1.66%)ChatGPT says Nvidia stock will hit this price by December 31, 20267:18:47 AM ETSHOP$132.57-23.63(-15.13%)Shopify Q3 revenue rises 32%, GMV hits $119 bln7:17:55 AM ETAMD$481.53+15.10(+3.24%)AMD Fell 16% in a Month Before Earnings. Forecasts Call for 501% Profit Growth in Four Years7:17:48 AM ETINTC$61.88+1.93(+3.22%)Amazon Vs. Intel: The Good Burn and The Very Bad Burn7:15:38 AM ETPLTR$167.76-10.60(-5.94%)Palantir Is Down 11% Over 12 Months: This Wall Street Pro Says 50% Gains to Come Over Next 12 Months as Momentum Rises7:15:07 AM ETAMZN$246.70+0.99(+0.40%)Here's Why You Buy Amazon Even As It Spends More on AI Than It Generates From Operations7:15:01 AM ETMU$863.14+29.85(+3.58%)Micron Said "Super Intelligence" Creates the Most Compelling Opportunity in Its History. Here's Why It Matters for Investors.7:15:00 AM ETXOM$180.49+0.73(+0.41%)ExxonMobil: The Tale Of 2 Countries - Guyana And Venezuela7:10:53 AM ETAAPL$324.64-13.95(-4.12%)Apple's John Ternus faces early test as global memory crisis hurts profits7:10:31 AM ETADT$9.850.00(0.00%)ADT Q3 revenue beats analyst estimates7:10:29 AM ETSHOP$132.57-23.63(-15.13%)BRIEF-Shopify Inc Q3 Revenue USD 3,742 Million7:09:48 AM ETUNH$396.97-3.41(-0.85%)UnitedHealth, Cleveland-Cliffs, Regeneron Pharmaceuticals And More: CNBC's ‘Final Trades'7:06:20 AM ETPLTR$167.76-10.60(-5.94%)Palantir stock is down 8%. Analysts say bookings growth is to blame.7:06:00 AM ETGOOGL$280.20+1.17(+0.42%)SUSTAINABLE SWITCH-Data center opposition hits the ballot box7:04:48 AM ETPFE$30.83+0.13(+0.42%)Pfizer hikes full-year outlook, taps company veteran as new CFO7:00:54 AM ETAAPL$324.64-13.95(-4.12%)Apple beat on earnings, so why is the stock falling?7:00:25 AM ETSHOP$132.57-23.63(-15.13%)Shopify Sustains Rapid Growth with Revenue Up 32% and Free Cash Flow Margin of 22%7:00:00 AM ETNEE$85.02-0.02(-0.02%)NextEra Energy and Dominion Energy strengthen historic Virginia benefits package with additional customer and financial safeguards7:00:00 AM ET

HSIC · NASDAQ

Henry Schein, Inc.

$82.00 -4.56 (-5.27%)

Company overview

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments: Health Care Distribution and Technology and Value-Added Services. The Health Care Distribution segment offers dental products including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services.

Sector
Healthcare
Industry
Medical - Distribution
Exchange
NASDAQ
Market cap
$9.1B
Employees
25,000
Headquarters
Melville, NY
CEO
Andrea Albertini
Listed
November 3, 1995
P/E
24.55
Dividend yield
0.00%

Company financials

Revenue
$13.4B
Gross profit
$4B
Operating income
$749M
EBITDA
$995M
Net income
$395M
EPS
$3.34
Total assets
$11.3B
Total debt
$3.7B
Gross margin
29.69%
Net margin
2.95%
Earnings yield
4.07%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

67.7674.1080.4486.7893.12
HSIC 1D NASDAQ O85.96H87.28L85.52C86.56+1.68 (+1.98%)Vol1.63M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
View
Ticker Type Headline Source Published
HSICHenry Schein, Inc. Stock news BUZZ-Henry Schein falls; co slightly misses Q3 sales estimates Reuters
HSICHenry Schein, Inc. Stock news Henry Schein Q3 sales slightly miss, raises 2026 profit outlook Reuters
HSICHenry Schein, Inc. Stock news BRIEF-Henry Schein Q3 Adjusted EPS USD 1.56 Vs. IBES Estimate USD 1.36 Reuters
HSICHenry Schein, Inc. Press release Henry Schein Reports Strong 2026 Third Quarter and Raises FY2026 Guidance Business Wire
HSICHenry Schein, Inc. Stock news Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term Zacks Investment Research
HSICHenry Schein, Inc. Stock news Analysts Estimate Henry Schein (HSIC) to Report a Decline in Earnings: What to Look Out for Zacks Investment Research
HSICHenry Schein, Inc. Stock news Henry Schein to Report Q3 Earnings: Here's What You Should Know Zacks Investment Research
HSICHenry Schein, Inc. Press release Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ET Business Wire
HSICHenry Schein, Inc. Stock news Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term Zacks Investment Research
HSICHenry Schein, Inc. Stock news Henry Schein (HSIC) is a Top-Ranked Value Stock: Should You Buy? Zacks Investment Research
HSICHenry Schein, Inc. Press release Henry Schein Announces Chief Financial Officer Leadership Transition Business Wire
HSICHenry Schein, Inc. Stock news HSIC or MMSI: Which Is the Better Value Stock Right Now? Zacks Investment Research
HSICHenry Schein, Inc. Stock news Should Value Investors Buy Henry Schein (HSIC) Stock? Zacks Investment Research
HSICHenry Schein, Inc. Press release Henry Schein Cares Marks 25 Years of Helping Health Happen® Business Wire
HSICHenry Schein, Inc. Stock news Here's Why Henry Schein (HSIC) is a Strong Growth Stock Zacks Investment Research
HSICHenry Schein, Inc. Stock news Henry Schein Still Gives Me A Reason To Smile After This Nice Move Higher Seeking Alpha
HSICHenry Schein, Inc. Stock news Are Investors Undervaluing Henry Schein (HSIC) Right Now? Zacks Investment Research
HSICHenry Schein, Inc. Stock news What Makes Henry Schein (HSIC) a New Buy Stock Zacks Investment Research
HSICHenry Schein, Inc. Stock news HSIC or SAUHY: Which Is the Better Value Stock Right Now? Zacks Investment Research
HSICHenry Schein, Inc. Stock news Here's Why Henry Schein (HSIC) is a Strong Value Stock Zacks Investment Research
FAQ

Questions about Henry Schein, Inc.

What does Henry Schein, Inc. do?
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments: Health Care Distribution and Technology and Value-Added Services. The Health Care Distribution segment offers dental products including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services.
What is HSIC's market cap?
Henry Schein, Inc. (HSIC) is a listed stock with a live quote. The latest market cap on this page is $9.1B.
Where is Henry Schein, Inc. headquartered?
Henry Schein, Inc. is headquartered in Melville, NY.
How do I get HSIC news from the API?
Call GET /v1/news?tickers=HSIC. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does HSIC news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for HSIC, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the HSIC price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.